ATOSSA THERAPEUTICS, INC. Stock-Based Compensation
ATOSSA THERAPEUTICS, INC. (ATOS) reported Stock-Based Compensation of $1.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $815.00K, a 2.39% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $722.00K, a 28.24% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $503.00K, a 35.01% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $784.00K, a 4.67% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $2.65M, a 15.45% increase from fiscal 2024.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $2.29M, a 50.40% decline from fiscal 2023.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $4.62M, a 31.92% decline from fiscal 2022.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $6.79M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed | Share-based Payment Arrangement, Noncash Expense 41 month | Share-based Payment Arrangement, Noncash Expense 44 month | Share-based Payment Arrangement, Noncash Expense 47 month | Share-based Payment Arrangement, Noncash Expense 50 month | Share-based Payment Arrangement, Noncash Expense 53 month | Share-based Payment Arrangement, Noncash Expense 56 month | Share-based Payment Arrangement, Noncash Expense 59 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $815.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.54M 10-Q · filed 2026-08-07 | $2.04M derived: sum of 3 quarters · filed 2026-08-07 | $2.82M derived: sum of 4 quarters · filed 2026-08-07 | |||||||||||
| 2026-03-31 | $722.00K 10-Q · filed 2026-05-08 | $1.23M derived: sum of 2 quarters · filed 2026-05-08 | $2.01M derived: sum of 3 quarters · filed 2026-05-08 | $2.81M derived: sum of 4 quarters · filed 2026-08-07 | |||||||||||
| 2025-12-31 | $503.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.29M derived: sum of 2 quarters · filed 2026-03-25 | $2.08M derived: sum of 3 quarters · filed 2026-08-07 | $2.65M 10-K · filed 2026-03-25 | |||||||||||
| 2025-09-30 | $784.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.58M derived: sum of 2 quarters · filed 2026-08-07 | $2.14M 10-Q · filed 2025-11-12 | $2.92M derived: sum of 4 quarters · filed 2026-08-07 | |||||||||||
| 2025-06-30 | $796.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.36M 10-Q · filed 2026-08-07 | $2.13M derived: sum of 3 quarters · filed 2026-08-07 | $2.88M derived: sum of 4 quarters · filed 2026-08-07 | |||||||||||
| 2025-03-31 | $563.00K 10-Q · filed 2026-05-08 | $1.34M derived: sum of 2 quarters · filed 2026-05-08 | $2.09M derived: sum of 3 quarters · filed 2026-05-08 | $2.44M derived: sum of 4 quarters · filed 2026-05-08 | |||||||||||
| 2024-12-31 | $774.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.52M derived: sum of 2 quarters · filed 2026-03-25 | $1.88M derived: sum of 3 quarters · filed 2026-03-25 | $2.29M 10-K · filed 2026-03-25 | |||||||||||
| 2024-09-30 | $749.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.10M derived: sum of 2 quarters · filed 2025-11-12 | $1.52M 10-Q · filed 2025-11-12 | $2.04M derived: sum of 4 quarters · filed 2025-11-12 | |||||||||||
| 2024-06-30 | $352.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $769.00K 10-Q · filed 2025-08-12 | $1.29M derived: sum of 3 quarters · filed 2025-08-12 | $2.21M derived: sum of 4 quarters · filed 2025-08-12 | |||||||||||
| 2024-03-31 | $417.00K 10-Q · filed 2025-05-13 | $936.00K derived: sum of 2 quarters · filed 2025-05-13 | $1.86M derived: sum of 3 quarters · filed 2025-05-13 | $3.46M derived: sum of 4 quarters · filed 2025-05-13 | |||||||||||
| 2023-12-31 | $519.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $1.45M derived: sum of 2 quarters · filed 2025-03-25 | $3.05M derived: sum of 3 quarters · filed 2025-03-25 | $4.62M 10-K · filed 2025-03-25 | |||||||||||
| 2023-09-30 | $926.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.53M derived: sum of 2 quarters · filed 2024-11-12 | $4.10M 10-Q · filed 2024-11-12 | ||||||||||||
| 2023-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $3.18M 10-Q · filed 2024-08-12 | |||||||||||||
| 2023-03-31 | $1.57M 10-Q · filed 2024-05-13 | ||||||||||||||
| 2022-12-31 | $6.79M 10-K · filed 2024-04-01 | ||||||||||||||
| 2018-06-30 | $179.05K 10-Q/A · filed 2018-11-13 | $1.56M 10-Q/A · filed 2018-11-13 | |||||||||||||
| 2017-06-30 | $181.41K 10-Q/A · filed 2018-11-13 | ||||||||||||||
| 2016-09-30 | $257.39K 10-Q · filed 2016-11-14 | $457.58K derived: sum of 2 quarters · filed 2016-11-14 | $650.05K 10-Q · filed 2016-11-14 | $856.17K derived: sum of 4 quarters · filed 2016-11-14 | |||||||||||
| 2016-06-30 | $200.19K 10-Q · filed 2016-08-12 | $392.66K 10-Q · filed 2016-08-12 | $598.78K derived: sum of 3 quarters · filed 2016-08-12 | $916.77K derived: sum of 4 quarters · filed 2016-11-14 | |||||||||||
| 2016-03-31 | $192.46K 10-Q · filed 2016-05-05 | $398.60K derived: sum of 2 quarters · filed 2016-05-05 | $716.58K derived: sum of 3 quarters · filed 2016-11-14 | $921.70K derived: sum of 4 quarters · filed 2016-11-14 | |||||||||||
| 2015-12-31 | $206.14K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $524.13K derived: sum of 2 quarters · filed 2016-11-14 | $729.24K derived: sum of 3 quarters · filed 2016-11-14 | $840.10K 10-K · filed 2016-03-30 | |||||||||||
| 2015-09-30 | $317.99K 10-Q · filed 2016-11-14 | $523.10K derived: sum of 2 quarters · filed 2016-11-14 | $633.96K 10-Q · filed 2016-11-14 | $703.73K 10-Q · filed 2015-11-12 | $683.14K derived: sum of 4 quarters · filed 2016-11-14 | ||||||||||
| 2015-06-30 | $205.11K 10-Q · filed 2016-08-12 | $353.98K 10-Q · filed 2016-08-12 | $385.74K 10-Q · filed 2015-08-06 | $365.15K derived: sum of 3 quarters · filed 2016-08-12 | $512.55K derived: sum of 4 quarters · filed 2016-08-12 | ||||||||||
| 2015-03-31 | $148.87K 10-Q · filed 2016-05-05 | $180.63K 10-Q · filed 2015-05-13 | $160.04K derived: sum of 2 quarters · filed 2016-05-05 | $307.44K derived: sum of 3 quarters · filed 2016-05-05 | $474.98K derived: sum of 4 quarters · filed 2016-05-05 | ||||||||||
| 2014-12-31 | $11.17K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $158.57K derived: sum of 2 quarters · filed 2016-03-30 | $326.11K derived: sum of 3 quarters · filed 2016-03-30 | $556.29K 10-K · filed 2016-03-30 | $698.66K 10-K · filed 2015-03-30 | ||||||||||
| 2014-09-30 | $147.40K 10-Q · filed 2014-11-12 | $314.93K derived: sum of 2 quarters · filed 2014-11-12 | $545.12K 10-Q · filed 2015-11-12 | $801.16K derived: sum of 4 quarters · filed 2015-05-13 | |||||||||||
| 2014-06-30 | $167.53K 10-Q · filed 2014-08-12 | $397.71K 10-Q · filed 2015-08-06 | $653.76K derived: sum of 3 quarters · filed 2015-05-13 | $842.52K derived: sum of 4 quarters · filed 2015-05-13 | |||||||||||
| 2014-03-31 | $230.18K 10-Q · filed 2015-05-13 | $486.22K derived: sum of 2 quarters · filed 2015-05-13 | $674.99K derived: sum of 3 quarters · filed 2015-05-13 | $1.41M derived: sum of 4 quarters · filed 2015-05-13 | $1.97M 10-Q · filed 2014-05-14 | ||||||||||
| 2013-12-31 | $256.04K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $444.81K derived: sum of 2 quarters · filed 2015-03-30 | $1.18M derived: sum of 3 quarters · filed 2015-03-30 | $1.44M 10-K · filed 2015-03-30 | $1.74M 10-K · filed 2014-03-27 | ||||||||||
| 2013-09-30 | $188.76K 10-Q · filed 2014-11-12 | $926.07K derived: sum of 2 quarters · filed 2014-11-12 | $1.19M 10-Q · filed 2014-11-12 | $1.23M derived: sum of 4 quarters · filed 2014-11-12 | $1.48M 10-Q · filed 2013-11-12 | ||||||||||
| 2013-06-30 | $737.31K 10-Q · filed 2014-08-12 | $1.01M 10-Q · filed 2014-08-12 | $1.04M derived: sum of 3 quarters · filed 2014-08-12 | $1.06M derived: sum of 4 quarters · filed 2014-08-12 | $1.30M 10-Q · filed 2013-08-14 | ||||||||||
| 2013-03-31 | $274.51K 10-Q · filed 2014-05-14 | $300.07K derived: sum of 2 quarters · filed 2014-05-14 | $325.66K derived: sum of 3 quarters · filed 2014-05-14 | $351.44K derived: sum of 4 quarters · filed 2014-05-14 | $566.78K 10-Q · filed 2013-05-15 | ||||||||||
| 2012-12-31 | $25.56K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $51.15K derived: sum of 2 quarters · filed 2014-03-27 | $76.93K derived: sum of 3 quarters · filed 2014-03-27 | $121.81K 10-K · filed 2014-03-27 | $292.26K 10-K · filed 2013-03-28 | ||||||||||
| 2012-09-30 | $25.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $51.37K derived: sum of 2 quarters · filed 2013-11-12 | $96.25K 10-Q · filed 2013-11-12 | $125.02K derived: sum of 4 quarters · filed 2013-11-12 | $266.70K 10-Q/A · filed 2013-01-22 | ||||||||||
| 2012-06-30 | $25.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $70.66K 10-Q · filed 2013-08-14 | $99.43K derived: sum of 3 quarters · filed 2013-08-14 | ||||||||||||
| 2012-03-31 | $44.88K 10-Q · filed 2013-05-15 | $73.65K derived: sum of 2 quarters · filed 2013-05-15 | |||||||||||||
| 2011-12-31 | $28.77K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28 | $140.06K 10-K · filed 2013-03-28 | |||||||||||||
| 2011-09-30 | $111.29K 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |